Document:

Warrant issued to Corporate Capital Group International Ltd. Inc.

  Exhibit 4.1
 THE WARRANT REPRESENTED BY THIS
CERTIFICATE AND THE OTHER SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR APPLICABLE STATE LAW, AND MAY NOT BE OFFERED OR SOLD EXCEPT (i) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND SUCH STATE LAW, (ii) TO THE EXTENT APPLICABLE, PURSUANT TO RULE 144 UNDER SUCH ACT (OR ANY SIMILAR RULE UNDER SUCH ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) UPON THE DELIVERY BY
THE HOLDER TO COMPANY OF AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO COUNSEL FOR COMPANY, STATING THAT AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND STATE LAW IS AVAILABLE.
 THIS WARRANT IS NONTRANSFERABLE, EXCEPT AS SET FORTH HEREIN
 Void after 5:00 p.m. California Time, on February
20, 2008.
 Warrant to Purchase 675,000 Shares of Common Stock
 WARRANT TO PURCHASE COMMON STOCK
 of
 CYTRX CORPORATION
 This is to Certify that, FOR VALUE RECEIVED, Corporate Capital Group International Ltd. Inc. or registered assigns
(“Holder”), is entitled to purchase, subject to the provisions of this Warrant, from CytRx Corporation, a Delaware corporation (“Company”), at any time on or after February 21, 2003, and not later than 5:00 p.m., California Time,
on February 20, 2008, 675,000 shares of common stock, $0.01 par value, of Company (“Common Stock”) at a purchase price per share of U.S. $0.20. The number of shares of Common Stock to be received upon the exercise of this Warrant and the
price to be paid for a share of Common Stock may be adjusted from time to time as hereinafter set forth. The shares of Common Stock deliverable upon such exercise, and as adjusted from time to time, are hereinafter sometimes referred to as
“Warrant Stock” and the exercise price of a share of Common Stock in effect at any time and as adjusted from time to time is hereinafter sometimes referred to as the “Exercise Price.”
 This Warrant is issued to Holder in connection with the Consulting/Engagement Letter between Holder and the Company dated as of February 21, 2003. 
 1.
Exercise of Warrant.
 (a)
This Warrant may be exercised in
whole or in part at any time or from time to time on or after February 21, 2003, and not later than 5:00 p.m., California Time, on February 20, 2008, or if February 20, 2008 is a day on which banking institutions are authorized by law to close, then
on the next succeeding day, which shall not be such a day, by presentation and surrender hereof to Company or at the office of its stock transfer agent, if any, with the Purchase Form annexed hereto, duly endorsed and accompanied by payment in full
of the Exercise Price
 

  for the number of shares specified in such form, together with all federal and state taxes applicable upon such exercise.
 (b)
Upon receipt by the Company of this Warrant at the
office or agency of the Company, in proper form for exercise, together with payment in full of the Exercise Price for the number of shares indicated in the Purchase Form, the Holder shall be deemed to be the holder of record of the shares of Common
Stock issuable upon such exercise, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such shares of Common Stock shall not then be actually delivered to the Holder.
 (c)
Company hereby agrees that at all times there shall be
reserved for issuance and delivery upon exercise of this Warrant such number of shares of its Common Stock as shall be required for issuance or delivery upon exercise of this Warrant.
 2.
Fractional Shares. No
fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. With respect to any fraction of a share called for upon any exercise hereof, Company shall pay to the Holder an amount in cash equal to such
fraction multiplied by the current “Fair Market Value” of a share of Common Stock, determined as follows:
 a.
If the Common Stock is listed on a national securities exchange or the Nasdaq National Market, the current Fair Market Value shall be the last
reported (as reported by Bloomberg’s Financial Service) sale price of the Common Stock on such exchange or the Nasdaq National Market on the last business day prior to the date of exercise of this Warrant or if no such sale is made on such day,
the average closing bid and asked prices for such day on such exchange or the Nasdaq National Market; or
 b.
If the Common Stock is not so listed, the current Fair Market Value shall be the mean of the last reported bid and asked prices reported by the
National Association of Securities Dealers Quotation System (or, if not so quoted on NASDAQ, by the National Quotation Bureau, Inc.) on the last business day prior to the date of the exercise of this Warrant; or
 c.
If the Common Stock is not so listed and bid and asked
prices are not so reported, the current Fair Market Value shall be an amount, not less than book value, determined in such reasonable manner as may be prescribed by the Board of Directors of the Company, such determination to be final and binding on
the Holder.
 3.
Exchange Assignment or Loss
of Warrant. This Warrant is exchangeable, without expense, at the option of the Holder, upon presentation and surrender hereof to Company or at the office of its stock transfer agent, if any, for other Warrants of different
denominations entitling the holder thereof to purchase in the aggregate the same number of shares of Common Stock purchasable hereunder. This Warrant may not be sold, transferred, assigned or hypothecated, except that it may be transferred by
operation of law as a result of the death of Holder or his lawful successors. Any such assignment shall be made by surrender of this Warrant to the Company or at the office of its stock transfer agent, if any, with the Assignment Form annexed hereto
duly executed and funds sufficient to pay any transfer tax; whereupon the
 
2

  Company shall, without charge, execute and deliver a new Warrant in the name of the assignee named in such instrument of assignment and this Warrant shall
promptly be canceled. This Warrant may be divided or combined with other Warrants which carry the same rights upon presentation hereof at the office of the Company or at the office of its stock transfer agent, if any, together with a written notice
specifying the names and denominations in which new Warrants are to be issued and signed by the Holder hereof. The term “Warrant” as used herein includes any Warrants issued in substitution for or replacement of this Warrant, or into which
this Warrant may be divided or exchanged. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and (in the case of loss, theft or destruction) of reasonably satisfied
indemnification, and upon surrender and cancellation of this Warrant, if mutilated, the Company will execute and deliver a new Warrant of like tenor and date. Any such new Warrant executed and delivered shall constitute an additional contractual
obligation on the part of the Company, whether or not this Warrant so lost, stolen, destroyed, or mutilated shall be at any time enforceable by anyone.
 4.
Rights of the Holder. The Holder shall not, by virtue hereof, be entitled to any rights of a
shareholder in the Company, either at law or equity, and the rights of the Holder are limited to those expressed in the Warrant and are not enforceable against Company except to the extent set forth herein.
 5.
Anti-Dilution Provisions.
 a.
Adjustment of Exercise
Price. Anything in this Section 5 to the contrary notwithstanding, in case the Company shall at any time issue Common Stock or Convertible Securities by way of dividend or other distribution on any stock of the Company
or subdivide or combine the outstanding shares of Common Stock, the Exercise Price shall be proportionately decreased in the case of such issuance (on the day following the date fixed for determining shareholders entitled to receive such dividend or
other distribution) or decreased in the cases of such subdivision or increased in the case of such combination (on the date that such subdivision or combination shall become effective).
 b.
No Adjustment for Small Amounts. Anything in this Section 5 to the contrary notwithstanding, the Company shall not be required to give effect to any adjustment in the Exercise Price unless and until the net effect of one or more adjustments, determined as above
provided, shall have required a change of the Exercise Price by at least one cent, but when the cumulative net effect of more than one adjustment so determined shall be to change the actual Exercise Price by at least one cent, such change in the
Exercise Price shall thereupon be given effect.
 c.
Number of Shares Adjusted. Upon any adjustment of the Exercise Price pursuant to Section 5(a), the Holder of this Warrant shall thereafter (until another such adjustment) be entitled to purchase, at the new Exercise
Price, the number of shares, calculated to the nearest full share, obtained by multiplying the number of shares of Common Stock initially issuable upon exercise of this Warrant by the original Exercise Price and dividing the product so obtained by
the new Exercise Price.
 
3

  6.
Officer’s
Certificate. Whenever the Exercise Price shall be adjusted as required by the provisions of Section 5 hereof, the Company shall forthwith file in the custody of its Secretary or an Assistant Secretary at its principal
office, and with its stock transfer agent, if any, an officer’s certificate showing the adjusted Exercise Price determined as herein provided and setting forth in reasonable detail the facts requiring such adjustment. Each such officer’s
certificate shall be made available at all reasonable times for inspection by the Holder and the Company shall, forthwith after each such adjustment, deliver a copy of such certificate to the Holder. Such certificate shall be conclusive as to the
correctness of such adjustment.
 7.
Notices
to Warrant Holder. So long as this Warrant shall be outstanding and unexercised (i) if Company shall pay any dividend or make any distribution upon the Common Stock or (ii) if Company shall offer to the holders of
Common Stock for subscription or purchase by them any shares of stock of any class or any other rights or (iii) if any capital reorganization of the Company, reclassification of the capital stock of the Company, consolidation or merger of the
Company with or into another corporation, sale, lease or transfer of all or substantially all of the property and assets of the Company to another corporation, or voluntary or involuntary dissolution, liquidation or winding up of the Company shall
be effected, then in any such case, the Company shall cause to be delivered to the Holder, at least ten days prior to the date specified in (x) or (y) below, as the case may be, a notice containing a brief description of the proposed action and
stating the date on which (x) a record is to be taken for the purpose of such dividend, distribution or rights, or (y) such reclassification, reorganization, consolidation, merger, conveyance, lease, dissolution, liquidation or winding up is to take
place and the date, if any, is to be fixed, as of which the holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reclassification, reorganization,
consolidation, merger, conveyance, dissolution, liquidation or winding up.
 8.
Reclassification, Reorganization or Merger. In case of any reclassification, capital reorganization or other change
of outstanding shares of Common Stock of the Company (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of an issuance of Common Stock by way of dividend or other distribution or
of a subdivision or combination), or in case of any consolidation or merger of the Company with or into another corporation (other than a merger with a subsidiary in which merger the Company is the continuing corporation and which does not result in
any reclassification, capital reorganization or other change of outstanding shares of Common Stock of the class issuable upon exercise of this Warrant) or in case of any sale or conveyance to another corporation of the property of the Company as an
entirety or substantially as an entirety, the Company shall cause effective provision to be made so that the holder shall have the right thereafter, by exercising this Warrant, to purchase the kind and amount of shares of stock and other securities
and property receivable upon such reclassification, capital reorganization or other change, consolidation, merger, sale or conveyance. Any such provision shall include provision for adjustments which shall be as nearly equivalent as may be
practicable to the adjustments provided for in this Warrant. The foregoing provisions of this Section (i) shall similarly apply to successive reclassifications, capital reorganizations and changes of shares of Common Stock and to successive
consolidations, mergers, sales or conveyances. In the event that in any such capital reorganization or reclassification, consolidation, merger, sale or conveyance, additional shares of Common Stock shall be issued in exchange, conversion,
substitution or payment, in whole or in
 
4

  part, for or of a security of the Company other than Common Stock, any such issue shall be treated as an issue of Common Stock covered by the provisions of
subsection (f)(i) hereof with the amount of the consideration received upon the issue thereof being determined by the Board of Directors of the Company, such determination to be final and binding on the Holder.
 9.
Spin-Offs. In the event the
Company spins-off a subsidiary by distributing to the shareholders of the Company as a dividend or otherwise the stock of the subsidiary, the Company shall reserve for the life of the Warrant shares of the subsidiary to be delivered to the Holder of
this Warrant upon exercise to the same extent as if such Holder were an owner of record of the Warrant Stock on the record date for payment of the shares of the subsidiary.
 10.
Notices. Any notices or
certificates by the Company to Holder shall be deemed delivered if in writing and delivered personally or sent by either certified mail or overnight mail (e.g., Federal Express or similar carrier) to Holder at the address for Holder registered on
the Company’s books, and by Holder to Company by notice in writing to the Company addressed to it at 11726 San Vicente Blvd., Suite 650, Los Angeles, CA 90049, to the attention of Steven A. Kriegsman, or such other address of which the Company
shall give notice. The Company may change its address by written notice to the Holder registered as the owner on the Company’s books and Holder may change its address by written notice to the Company.
 11.
Transfer Restrictions. This
Warrant may not be assigned, transferred, sold or otherwise disposed of, except by intestate succession or by will.
 12.
Restrictive Legend. The Company may cause the following legend to be set forth on each certificate representing
Warrant Stock or any other security issued or issuable upon exercise of this Warrant, unless counsel for the Company is of the opinion as to any such certificate that such legend is unnecessary:
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT MADE UNDER THE SECURITIES ACT OF 1933
(THE “ACT”) AND APPLICABLE STATE LAW, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND SUCH STATE LAW.
 13.
Applicable Law. This Warrant shall be governed by, and construed in accordance with, the internal laws of the State
of California.
  

	 Dated: February 21, 2003
 	  
 	  
 	  
 
	 By
 	 
 /s/ STEVEN A. KRIEGSMAN
 	  
 	  
 	  
 
	  
 	 
 	  
 	  
 	  
 
	  
 	 Steven A. Kriegsman
 	  
 	  
 	  
 

 
5

  PURCHASE FORM
 Date
___________, 200_
 o   The undersigned hereby irrevocably elects to exercise the within Warrant to the extent of
purchasing _____ shares of Common Stock and hereby makes payment of $___________ in payment of the actual exercise price thereof.
 INSTRUCTIONS FOR REGISTRATION
OF STOCK
 NAME:_______________________________________________________
                                       
 (Please type or print in block letters)
 NAME:_______________________________________________________
 ADDRESS:____________________________________________________
 SIGNATURE:__________________________________________________
 ASSIGNMENT FORM
 FOR VALUE RECEIVED,___________________________________________
 hereby sells, assigns and transfers unto:
 NAME: _______________________________________________________
                                       
 (Please type or print in block letters)
 ADDRESS:_____________________________________________________
 the right to purchase Common Stock represented by this Warrant to the extent of_____ shares as to which such right is exercisable and does hereby irrevocably constitute and appoint
______________________________________, attorney, to transfer the same on the books of the Company with fill power of substitution in the premises.
 Date:_______________,
200__
  

	  
 	  
 	  
 	  
 
	  
 	  
 	  
  
 	  
 	 By: 
 	 
 
 
 
	  
 	  
 	  
 	  
 	  
 	 
 
	  
 	  
 	  
 	  
 	 Name: 
 	  
 
	  
 	  
 	  
 	  
 	  
 	  
 

 
6Agreement between Kriegsman Capital Group and CytRx

  Exhibit 10.1
 PROFESSIONAL SERVICES
AGREEMENT
 This Professional Services Agreement, dated as of January 29, 2003, is made by and between CytRx Corporation (“CytRx”), The
Kriegsman Group, an institutional division of Financial West Group (“TKG”), and Kriegsman Capital Group (“KCG”) with reference to the following facts:
 A.
TKG and KCG are wholly owned affiliates of Steven A. Kriegsman.
 B.
Pursuant to an agreement dated February 11, 2002
between CytRx and KCG (the “Prior Agreement”), TKG has been furnishing since July 16, 2002 certain office space (“Space”) and professional services (“Services”) to CytRx and CytRx has made payments to KCG for such
Space and Services, which payments have been assigned by KCG to TKG.
 C.
CytRx and TKG have reviewed the amount of Space and Services that were furnished by TKG to CytRx for the period from July 16, 2002 through
November 30, 2002 (the “Prior Period”) and have determined that an amount in addition to those amounts previously paid by CytRx to KCG should be paid by CytRx to KCG under the Prior Agreement for the Prior Period.
 D.
CytRx, TKG and KCG wish to revise and restate the Prior
Agreement to provide that the Space and Services are being provided by TKG to CytRx and to cover the payment to be made by CytRx to TKG for Space and Services to be provided to CytRx subsequent to November 30, 2002.
 The parties hereby agree as follows:
 1.
Payment for Prior Period. CytRx and KCG hereby agree that the total amount owing for Space and Services provided by
KCG during the Prior Period shall be $50,310.86, against which $39,712 had been previously paid by CytRx. In December 2002, CytRx paid KCG an additional $10,598.86 as payment in full for all remaining amounts owed to KCG for Space and Services for
the Prior Period.
 2.
Monthly Space and
Services Payment. Commencing on December 1, 2002, TKG became responsible for providing the Space and Services to CytRx and KCG shall have no further rights or obligations with respect to providing the Space and Services under
the Prior Agreement or this Agreement. CytRx shall pay TKG a monthly amount (the “Monthly Payment”), which shall be paid on the 15th day of each such month, with the first payment to be made on December 15, 2002. The amount of
the Monthly Payment has been calculated based on the provision by TKG to CytRx of the following:
 (i)
Space conforming to the specific space and percentage of usage set forth in Exhibit A hereto.
 
 

  (ii)
Services provided by
the personnel listed in Exhibit B hereto (other than Kathy Hernandez), at the monthly salaries and in the percentages allocable to CytRx as set forth in Exhibit B. The Services shall consist of the services described in Exhibit B.
Personnel shall not be added to Exhibit B or Services modified from those described in Exhibit B without the prior written consent of CytRx.
 (iii)
A portion of the services provided by Kathy Hernandez as CytRx’s Secretary for the months of December 2002 and
January 2003, based on allocating approximately 93.5% of her time to CytRx and 6.5% of her time to TKG, with her total salary to be allocated between CytRx and TKG being $7,291.66 for each of those two months. ($2,500 of her total December 2002
salary and $2,500 of her total January 2003 salary will be paid to her by CytRx and $4,719.66 of her total December 2002 salary and $4,719.66 of her total January 2003 salary will be paid to her by TKG.) Effective February 1, 2003, CytRx will
directly pay her entire salary ($5,833.33 for February 2003 and each month thereafter) and any related payroll costs. The amount of the Monthly Payment, accordingly, will be adjusted as of February 1, 2003 as described below, and TKG shall make
a monthly payment to CytRx of $379.15 on the 15th day of each month commencing with February 2003, which is based on allocating approximately 93.5% of Ms. Hernandez’s time to CytRx and 6.5% of her time to TKG, with her total
salary to be allocated between CytRx and TKG being $5,833.33 per month for the month of February 2003 and each month thereafter.
 The Monthly Payment for
December 2002 and January 2003 shall be $10,728.19 and shall be $6,415.70 for subsequent monthly periods.
 3.
Future Adjustments to Monthly Payment. The Monthly Payment shall be reviewed by CytRx and TKG on a quarterly basis
(with the first review to be as of March 31, 2003) to make appropriate adjustments as shall be agreed to by CytRx and TKG to reflect changes in the rental rates paid by TKG for and percentage usage by CytRx of the Space and to salary levels of
and percentage usage by CytRx of the personnel providing the Services. The monthly payment to be made by TKG to CytRx for the services of Kathy Hernandez shall also be reviewed by CytRx and TKG on a quarterly basis (with the first review to be as of
March 31, 2003) to make appropriate changes as shall be agreed to by CytRx and TKG to reflect changes in Ms. Hernandez’s salary level and the percentage usage of her time by TKG.
 4.
Miscellaneous. This Agreement
shall be governed by and construed in accordance with the internal laws of the State of California. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be
deemed one and the same document. This Agreement may not be amended without the prior written consent of each of the parties hereto. Any amendment to this Agreement or increase in the amount of the Monthly Payment from the amounts specified in
Section 2 shall require the approval of CytRx’s Board of Directors. This Agreement may not be assigned or transferred by either party hereto without the consent of the other party hereto. Either party may terminate this Agreement at any time
upon thirty days prior written notice without any further liability among the parties hereto,
 
2

  other than the accrued Monthly Amount (including any pro rata amount for a partial month) through the effective time of such termination. This Agreement
shall terminate automatically and without any further action by the parties hereto upon the termination of Steven A. Kriegsman’s employment with CytRx and CytRx shall have no further liability to TKG hereunder other than the accrued
Monthly Payment through the date of such termination.
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.
  

	  
 	 CYTRX CORPORATION
 	  
 	 KRIEGSMAN CAPITAL GROUP, LLC
 
	  
 	 By: 
 	 
 /s/ MAX LINK
 	  
 	 By: 
 	 
 /s/ STEVEN A. KRIEGSMAN
 
	  
 	  
 	 
 	  
 	  
 	 
 
	  
 	  
 	 Max Link
 Chairman of the Board
 	  
 	  
 	 Steven A. Kriegsman
 
 
 

  
  

	  
 	 THE KRIEGSMAN GROUP, An
 Institutional Division of Financial West Group
 	  
 	  
 
	  
 	 By: 
 	 
 /s/ STEVEN A. KRIEGSMAN
 	  
 	  
 	 
 
 
 
	  
 	  
 	 
 	  
 	  
 	  
 
	  
 	  
 	 Steven A. Kriegsman
 	  
 	  
 	  
 

 
3

  EXHIBIT A
 CYTRX OFFICE
SPACE
  

	  
 	  
 	 Square
 footage
 	  
 	 % used by
  CytRx
 	  
 	 Approximate Cytrx
 footage
 	  
 
	  
 	  
 	 
 	  
 	 
 	  
 	 
 	  
 
	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 
	 Steve office
 	  
 	 210
 	  
 	 75
 	  
 	 158
 	  
 
	 Elliott office
 	  
 	 195
 	  
 	 100
 	  
 	 195
 	  
 
	 Work office
 	  
 	 195
 	  
 	 0
 	  
 	 0
 	  
 
	 Board room
 	  
 	 210
 	  
 	 75
 	  
 	 158
 	  
 
	 Ed/Dave
 	  
 	 196
 	  
 	 40
 	  
 	 78
 	  
 
	 Kathy/Temp
 	  
 	 120
 	  
 	 95
 	  
 	 114
 	  
 
	 Reception
 	  
 	 70
 	  
 	 20
 	  
 	 14
 	  
 
	 Work area
 	  
 	 105
 	  
 	 33
 	  
 	 35
 	  
 
	 Kitchen
 	  
 	 133
 	  
 	 33
 	  
 	 44
 	  
 
	 *Other area
 	  
 	 1322
 	  
 	 0
 	  
 	 0
 	  
 
	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 
	 Total Area
 	  
 	 2756
 	  
 	 29%
 	  
 	 796
 	  
 

 
 TKG Monthly Rent:
**$9,686.59
 CytRx portion of rent should be: $2,809.20
 *
includes walkways that are used for Cytrx but is not being included in the
calculation
 **
includes $21.00 common area maintenance fee
 CURRENT OFFICE SPACE USAGE
 

  EXHIBIT B
 CytRx work performed July 16, 2002 to
current date, and to continue to be performed until further notice to the Board.
  

	 Employee
 	  
 	 TKG Monthly
  salary
 	  
 	 CytRx Duties
 	  
 	 Time
 	  
 	 % work for 
 CytRx
 	  
 	 CytRx 
 portion
 	  
 
	 
 	  
 	 
 	  
 	 
 	  
 	 
 	  
 	 
 	  
 	 
 	  
 
	 David Haen
 	  
 	 $ 3,105.00
 	  
 	 Assists in identifying and structuring potential business opportunities (in-licensing, outlicensing, M&A), researches current healthcare transactions and
trends, helps with other administrative duties for both Steve and Elliott on an ongoing basis
 	  
 	 Continual
 	  
 	 30%
 	  
 	 $  930.50
 	  
 
	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 
	 Carolyn French
 	  
 	 $ 2,375.00
 	  
 	 Answer phones, assist Corporate Secretary, assemble investor packages
 	  
 	 Continual
 	  
 	 20%
 	  
 	 $  475.00
 	  
 
	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 
	 Ed Umali
 	  
 	 $ 5,500.00
 	  
 	 Assist Scientific Consultant with power point and other presentations, assist Financial Consultant with payroll and invoices, assist attorney with corporate
files, oversee Atlanta facility, supervise Los Angeles phones and information systems, organized CytRx files in storage
 	  
 	 Continual
 	  
 	 40%
 	  
 	 $ 2,200.00
 	  
 
	  
 	  
 	 
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	 
 	  
 
	  
 	  
 	 $10,980.00
 	  
 	  
 	  
 	  
 	  
 	  
 	  
 	 $3,605.50

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00052-of-00352.parquet"}]]